U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 4982

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:45288269
GRCh38:
Chr1:44822597
PTCH2G1144RGorlin syndromeUncertain significance
(Jul 11, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr10:104375147-104375150
GRCh38:
Chr10:102615390-102615393
SUFUL383fsGorlin syndromePathogenic
(May 23, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr1:45297657
GRCh38:
Chr1:44831985
PTCH2M172TGorlin syndromeUncertain significance
(May 31, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr1:45294895-45294898
GRCh38:
Chr1:44829223-44829226
PTCH2L435PGorlin syndromePathogenic
(Jul 5, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr9:98244323
GRCh38:
Chr9:95482041
PTCH1Gorlin syndromeLikely pathogenic
(Jun 14, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr9:98221953
GRCh38:
Chr9:95459671
PTCH1A788G, A873G, A887G, A938G, A939GGorlin syndromeUncertain significance
(Apr 13, 2023)
no assertion criteria provided
7.
GRCh37:
Chr1:45292937
GRCh38:
Chr1:44827265
PTCH2T806AGorlin syndromeUncertain significance
(Dec 8, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr9:98220539
GRCh38:
Chr9:95458257
PTCH1P824fs, P909fs, P923fs, P974fs, P975fsGorlin syndromePathogenic
(Feb 23, 2023)
criteria provided, single submitter
9.
GRCh37:
Chr9:98231196-98231197
GRCh38:
Chr9:95468914-95468915
LOC100507346, PTCH1T545fs, T630fs, T644fs, T695fs, T696fsGorlin syndromeLikely pathogenic
(Feb 23, 2023)
criteria provided, single submitter
10.
GRCh37:
Chr9:98279012
GRCh38:
Chr9:95516730
PTCH1Y31fsGorlin syndromeLikely pathogenic
(Feb 23, 2023)
criteria provided, single submitter
11.
GRCh37:
Chr9:98268792-98268793
GRCh38:
Chr9:95506510-95506511
PTCH1N31fs, N96fs, N97fsGorlin syndromeLikely pathogenic
(Feb 23, 2023)
criteria provided, single submitter
12.
GRCh37:
Chr9:98229670-98229671
GRCh38:
Chr9:95467388-95467389
LOC100507346, PTCH1V612fs, V697fs, V711fs, V762fs, V763fsGorlin syndromeLikely pathogenic
(Jan 12, 2023)
criteria provided, single submitter
13.
GRCh37:
Chr9:98242836
GRCh38:
Chr9:95480554
PTCH1P110A, P195A, P260A, P261AGorlin syndromeUncertain significance
(Mar 9, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr9:98240460
GRCh38:
Chr9:95478178
PTCH1Gorlin syndromeLikely benign
(May 21, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr1:45295334-45295337
GRCh38:
Chr1:44829662-44829665
PTCH2S344fsGorlin syndromeUncertain significance
(Apr 8, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr9:98222062
GRCh38:
Chr9:95459780
PTCH1T752A, T837A, T851A, T902A, T903AGorlin syndromeUncertain significance
(May 14, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr10:104262628-104309873
SUFUMedulloblastoma, Gorlin syndromeUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr1:45290013-45292899
PTCH2Gorlin syndromeUncertain significance
(Dec 17, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr1:45288087-45308604
PTCH2Gorlin syndromeUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr9:98244399
GRCh38:
Chr9:95482117
PTCH1Gorlin syndromeLikely benign
(May 2, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr9:98270587-98270592
GRCh38:
Chr9:95508305-95508310
PTCH1Gorlin syndromeUncertain significance
(Dec 11, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr9:98244222
GRCh38:
Chr9:95481940
PTCH1Gorlin syndromeLikely benign
(Jan 6, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr9:98212154
GRCh38:
Chr9:95449872
PTCH1V1022A, V1107A, V1121A, V1172A, V1173AGorlin syndromeUncertain significance
(May 1, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr9:98238454
GRCh38:
Chr9:95476172
PTCH1Gorlin syndromeLikely benign
(Oct 27, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr1:45292563
GRCh38:
Chr1:44826891
PTCH2Gorlin syndromeLikely benign
(Mar 4, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr9:98209271
GRCh38:
Chr9:95446989
PTCH1R1272G, R1357G, R1371G, R1422G, R1423GGorlin syndromeUncertain significance
(Jan 13, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr1:45294091
GRCh38:
Chr1:44828419
PTCH2Gorlin syndromeLikely benign
(Apr 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr10:104375178-104375179
GRCh38:
Chr10:102615421-102615422
SUFUMedulloblastoma, Gorlin syndromeLikely benign
(Aug 26, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr10:104375149
GRCh38:
Chr10:102615392
SUFUL383FMedulloblastoma, Gorlin syndrome, Hereditary cancer-predisposing syndrome
Uncertain significance
(Dec 7, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr1:45292697
GRCh38:
Chr1:44827025
PTCH2M858VGorlin syndromeUncertain significance
(Feb 27, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr1:45297432
GRCh38:
Chr1:44831760
PTCH2P188RInborn genetic diseases, Gorlin syndromeUncertain significance
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:45288857
GRCh38:
Chr1:44823185
PTCH2Gorlin syndromeLikely benign
(May 25, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr1:45293953-45293954
GRCh38:
Chr1:44828281-44828282
PTCH2Gorlin syndromeUncertain significance
(Sep 30, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr9:98270592
GRCh38:
Chr9:95508310
PTCH1S18CGorlin syndromeBenign
(Sep 19, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr9:98229554
GRCh38:
Chr9:95467272
LOC100507346, PTCH1N736D, N651D, N801D, N750D, N802DGorlin syndromeUncertain significance
(Dec 11, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr1:45307584
GRCh38:
Chr1:44841912
PTCH2G67AGorlin syndromeUncertain significance
(Sep 10, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr9:98229722
GRCh38:
Chr9:95467440
LOC100507346, PTCH1Gorlin syndromeLikely benign
(May 2, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr1:45294055
GRCh38:
Chr1:44828383
PTCH2A541VGorlin syndromeUncertain significance
(Dec 24, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr9:98244261
GRCh38:
Chr9:95481979
PTCH1A173V, A88V, A238V, A239VGorlin syndromeUncertain significance
(Jul 5, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr9:98229711
GRCh38:
Chr9:95467429
LOC100507346, PTCH1Gorlin syndromeLikely benign
(Sep 19, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr9:98240484
GRCh38:
Chr9:95478202
PTCH1Gorlin syndromeLikely benign
(Feb 4, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr9:98242386
GRCh38:
Chr9:95480104
PTCH1Gorlin syndromeLikely benign
(Apr 13, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr1:45294891
GRCh38:
Chr1:44829219
PTCH2V437MGorlin syndromeUncertain significance
(Jul 13, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr9:98232170
GRCh38:
Chr9:95469888
LOC100507346, PTCH1I525T, I440T, I591T, I539T, I590TGorlin syndromeUncertain significance
(Mar 14, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr9:98244429
GRCh38:
Chr9:95482147
PTCH1G148D, G213D, G63D, G214DGorlin syndromeUncertain significance
(Apr 30, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr9:98218712
GRCh38:
Chr9:95456430
PTCH1Gorlin syndromeLikely benign
(Oct 17, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:45288785
GRCh38:
Chr1:44823113
PTCH2V1105MInborn genetic diseases, Gorlin syndromeUncertain significance
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr1:45297641
GRCh38:
Chr1:44831969
PTCH2Gorlin syndromeUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr1:45292977
GRCh38:
Chr1:44827305
PTCH2Gorlin syndromeLikely benign
(Sep 16, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr9:98222066
GRCh38:
Chr9:95459784
PTCH1Gorlin syndromeLikely pathogenic
(Oct 25, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr1:45294747
GRCh38:
Chr1:44829075
PTCH2Gorlin syndromeUncertain significance
(Aug 2, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr9:98242272
GRCh38:
Chr9:95479990
PTCH1N283S, N349S, N198S, N348SHereditary cancer-predisposing syndrome, Gorlin syndromeUncertain significance
(Mar 2, 2023)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr1:45293812
GRCh38:
Chr1:44828140
PTCH2Gorlin syndromeLikely benign
(May 19, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr9:98270488
GRCh38:
Chr9:95508206
PTCH1Hereditary cancer-predisposing syndrome, Gorlin syndromeLikely benign
(May 21, 2023)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr9:98220561
GRCh38:
Chr9:95458279
PTCH1P902S, P916S, P967S, P817S, P968SGorlin syndromeUncertain significance
(Jan 4, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr9:98209208
GRCh38:
Chr9:95446926
PTCH1S1443R, S1293R, S1444R, S1378R, S1392RGorlin syndromeUncertain significance
(Jan 21, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr9:98209728
GRCh38:
Chr9:95447446
PTCH1Hereditary cancer-predisposing syndrome, Gorlin syndromeLikely benign
(Nov 7, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr1:45293525
GRCh38:
Chr1:44827853
PTCH2S683LGorlin syndromeUncertain significance
(Feb 22, 2023)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr9:98229537
GRCh38:
Chr9:95467255
LOC100507346, PTCH1Gorlin syndromeLikely benign
(Mar 31, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr9:98242331
GRCh38:
Chr9:95480049
PTCH1Gorlin syndromeLikely benign
(Sep 14, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr9:98268859
GRCh38:
Chr9:95506577
PTCH1A74V, A9V, A75VGorlin syndromeUncertain significance
(Dec 20, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr9:98218691
GRCh38:
Chr9:95456409
PTCH1M1058T, M1057T, M907T, M992T, M1006TGorlin syndromeUncertain significance
(Jul 17, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr9:98268753
GRCh38:
Chr9:95506471
PTCH1Gorlin syndromeLikely benign
(Aug 18, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr10:104389844
GRCh38:
Chr10:102630087
SUFUS463GGorlin syndrome, MedulloblastomaUncertain significance
(Mar 15, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr1:45307531
GRCh38:
Chr1:44841859
PTCH2L85FGorlin syndromeUncertain significance
(Feb 25, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr10:104352324
GRCh38:
Chr10:102592567
SUFUMedulloblastoma, Gorlin syndromeLikely benign
(Jul 15, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr10:104375136
GRCh38:
Chr10:102615379
SUFUMedulloblastoma, Gorlin syndromeLikely benign
(Dec 30, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr9:98244275
GRCh38:
Chr9:95481993
PTCH1Gorlin syndromeLikely benign
(Feb 10, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr1:45293133
GRCh38:
Chr1:44827461
PTCH2P771HGorlin syndromeUncertain significance
(Sep 25, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr9:98224271
GRCh38:
Chr9:95461989
PTCH1D791G, D856G, D857G, D706G, D805GGorlin syndromeBenign
(Oct 7, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr1:45293260
GRCh38:
Chr1:44827588
PTCH2A729SGorlin syndromeUncertain significance
(Oct 4, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr1:45295378
GRCh38:
Chr1:44829706
PTCH2H331YGorlin syndromeUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr9:98270458
GRCh38:
Chr9:95508176
PTCH1Gorlin syndromeUncertain significance
(Jan 20, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr1:45293193
GRCh38:
Chr1:44827521
PTCH2H751LGorlin syndromeUncertain significance
(Oct 16, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr1:45293810
GRCh38:
Chr1:44828138
PTCH2T588IGorlin syndromeUncertain significance
(May 17, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr9:98270462
GRCh38:
Chr9:95508180
PTCH1A61VGorlin syndromeUncertain significance
(Apr 8, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr1:45307680
GRCh38:
Chr1:44842008
PTCH2W35SGorlin syndromeUncertain significance
(Dec 31, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr1:45293228
GRCh38:
Chr1:44827556
PTCH2Gorlin syndromeLikely benign
(Apr 15, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr1:45297486
GRCh38:
Chr1:44831814
PTCH2Gorlin syndromeLikely benign
(Oct 19, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr1:45294199-45294200
GRCh38:
Chr1:44828527-44828528
PTCH2L524fsGorlin syndromeUncertain significance
(Aug 20, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr1:45288769
GRCh38:
Chr1:44823097
PTCH2L1110PGorlin syndromeUncertain significance
(May 29, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr1:45292159
GRCh38:
Chr1:44826487
PTCH2Gorlin syndromeUncertain significance
(Apr 13, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr9:98248080
GRCh38:
Chr9:95485798
PTCH1Gorlin syndromeLikely benign
(May 12, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr10:104389891
GRCh38:
Chr10:102630134
SUFUMedulloblastoma, Gorlin syndromeLikely benign
(Apr 3, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr9:98239153-98239154
GRCh38:
Chr9:95476871-95476872
PTCH1Gorlin syndromeLikely benign
(Mar 17, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr9:98244495
GRCh38:
Chr9:95482213
PTCH1Gorlin syndromeLikely benign
(Jul 6, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr9:98215817
GRCh38:
Chr9:95453535
PTCH1V1065A, V1130A, V980A, V1131A, V1079AHereditary cancer-predisposing syndrome, Gorlin syndromeConflicting interpretations of pathogenicity
(May 2, 2023)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr1:45292437
GRCh38:
Chr1:44826765
PTCH2P900LGorlin syndromeUncertain significance
(Aug 3, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr9:98229480
GRCh38:
Chr9:95467198
LOC100507346, PTCH1F825L, F826L, F675L, F760L, F774LGorlin syndromeUncertain significance
(Sep 4, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr10:104264046
GRCh38:
Chr10:102504289
SUFUP46RMedulloblastoma, Gorlin syndromeUncertain significance
(Jul 31, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr9:98211530
GRCh38:
Chr9:95449248
PTCH1M1058V, M1143V, M1209V, M1208V, M1157VGorlin syndromeBenign
(Oct 23, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr10:104352376
GRCh38:
Chr10:102592619
SUFUMedulloblastoma, Gorlin syndromeLikely benign
(Jul 18, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr1:45293848
GRCh38:
Chr1:44828176
PTCH2Gorlin syndromeUncertain significance
(May 18, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr9:98231442
GRCh38:
Chr9:95469160
LOC100507346, PTCH1Gorlin syndromeLikely benign
(Apr 7, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr1:45307582
GRCh38:
Chr1:44841910
PTCH2A68TGorlin syndromeUncertain significance
(Feb 24, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr1:45294720
GRCh38:
Chr1:44829048
PTCH2Gorlin syndromeLikely benign
(Oct 17, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr9:98270510
GRCh38:
Chr9:95508228
PTCH1P45LGorlin syndromeUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr1:45293633
GRCh38:
Chr1:44827961
PTCH2G647DGorlin syndromeUncertain significance
(Jan 21, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr1:45294892
GRCh38:
Chr1:44829220
PTCH2Gorlin syndromeLikely benign
(Apr 13, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr9:98209324
GRCh38:
Chr9:95447042
PTCH1D1339G, D1254G, D1353G, D1405G, D1404GGorlin syndromeUncertain significance
(Jul 29, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination